文献速递炎症性肠病

炎症性肠病患者类固醇过度处方的来源及其相关临床不良结局:利兹IBD类固醇研究

Sources of excess steroid prescriptions and clinical adverse outcomes associated with steroid excess in patients with inflammatory bowel disease: The Leeds IBD Steroids study.
PubMed 文献 · Aliment Pharmacol Ther · 2022-05-24

该研究纳入2246例有初级保健关联信息的IBD门诊患者,33%在2年内暴露于类固醇,其中28%处方来自初级保健。初级保健处方剂量和疗程更常不适当(85% vs 41%,p<0.001),且更常发生进一步 flare(50% vs 39%,p=0.003)。类固醇过量与IBD住院、感染住院及抗生素处方风险升高相关,需加强初级与次级保健间的联络。

要点

  • 33%的IBD患者在2年内暴露于类固醇,28%的处方来自初级保健。
  • 次级保健处方的剂量和疗程更常适当(85% vs 41%,p<0.001)。
  • 类固醇过量与IBD住院(OR=12.33)、感染住院(OR=2.89)及抗生素处方(OR=1.41)相关。

核心结论

  • 患者常通过初级保健获得类固醇,但剂量和疗程常不适当,且患者更可能发生flare。
  • 类固醇过量与IBD住院、感染住院及抗生素处方相关。
  • 需要改善初级与次级保健之间的联络以减少类固醇过量。

研究设计与样本

  • 纳入就诊于IBD门诊且有初级保健关联信息的患者,共2246例。
  • 评估与处方来源相关的治疗升级的适当性和及时性以及类固醇过量的可避免性。

主要发现

  • 2246例患者中,33%在2年内暴露于类固醇,初级保健开具28%的处方。
  • 次级保健处方更常具有适当的剂量和疗程(85% vs 41%,p<0.001)。
  • 初级保健处方类固醇的患者中50%发生进一步flare(vs 39%;p=0.003)。
  • 15%的患者观察到类固醇过量。
  • 类固醇过量且初级保健处方未传达至次级保健的患者更少接受及时治疗升级(49% vs 66%,p=0.042),类固醇过量更常可避免(73% vs 56%,p=0.022)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Corticosteroids remain important for managing inflammatory bowel disease (IBD) flares. Steroid excess, however, may be a marker of poor care. Patients access steroid prescriptions from primary (General Practitioners [GP]) or secondary care (hospital-based). Sources of prescriptions and associated outcomes are not well described. METHODS: Patients attending IBD clinics with linked primary care information were included. We examined appropriateness and timeliness of treatment escalation and avoidability of steroid excess in relation to prescription sources. RESULTS: Of 2246 patients, 33% were exposed to steroids over 2 years. Primary care issued 28% of prescriptions. Secondary care prescriptions were more often of appropriate dose and duration (85% vs 41%, p < 0.001). Further flares occurred in 50% of patients prescribed steroids from primary care (vs 39%; p = 0.003). Steroid excess was observed in 15%. Patients with steroid excess who received prescriptions from primary care that were not communicated to secondary care less often received timely treatment escalation (49% vs 66%, p = 0.042) and steroid excess was more often avoidable (73% vs 56%, p = 0.022). Patients with steroid excess had higher risks of hospitalisation for IBD (OR = 12.33, 95% CI [8.89-17.11]), hospitalisation for infections (OR = 2.89, 95% CI [1.82-4.61]) and GP prescribed antibiotics (OR = 1.41, 95% CI [1.07-1.86]). CONCLUSION: Patients commonly access steroids through primary care, but doses and durations are frequently inappropriate with patients more likely to flare. Steroid excess was associated with IBD admissions, admissions for infections and antibiotic prescriptions. Improved liaison between primary and secondary care is required to reduce steroid excess.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Rosiou K, Carbonell J, Dolby V, et al. Sources of excess steroid prescriptions and clinical adverse outcomes associated with steroid excess in patients with inflammatory bowel disease: The Leeds IBD Steroids study. Aliment Pharmacol Ther. 2022. PMID: 35611471. doi:10.1111/apt.17039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。